November 2019 FDA Recall Hydrocodone Bitartrate And Homatropine Methylbromide by Kvk-tech, Inc.
D-0532-2020 - Presence of Foreign Substance

This Class II drug recall was voluntarily initiated by Kvk-tech, Inc. on November 1, 2019 for the product Hydrocodone Bitartrate And Homatropine Methylbromide. The FDA reported the reason for recall as presence of foreign substance. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0532-2020

Reason for Recall
Presence of Foreign Substance: Black particles were found in the lots during retain sample inspection
Initiated
11-01-2019
Reported
11-20-2019
Quantity
1534 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide within the United States
Hydrocodone Bitartrate and Homatropine Methlybromide Oral Solution 5 mg/1.5 mg per 5 mL, 473 mL bottles, Rx only, Mfd. by: KVK-Tech, Inc. Newtown PA 18940; NDC 10702-150-16

Batch or Lot Expiration Information

Lot# : 14375A, Exp. date 2019-DEC; 14398A, Exp. date 2020-JAN